Thermo Fisher Scientific Inc., a key player in the healthcare sector, exhibits a modest dividend yield with consistent dividend history. The company maintains a strong financial footing, evident from its moderate payout ratios and robust cash flow metrics, making it an appealing option for dividend-focused investors.
Thermo Fisher Scientific Inc. operates within the healthcare sector, offering a dividend yield of 0.35%. With a current dividend of $1.69 per share and a commendable 16-year dividend history, the company's consistent performance in sustaining dividends is noteworthy. There has been no recent cut or suspension.
| Metric | Detail |
|---|---|
| Sector | Healthcare |
| Dividend Yield | 0.35% |
| Current Dividend per Share | $1.69 USD |
| Dividend History | 16 years |
| Last Cut or Suspension | None |
The company’s dividend history showcases stability and a commitment to returning value to shareholders. This consistency is a crucial metric, signaling reliability in dividend payments.
| Year | Dividend per Share (USD) |
|---|---|
| 2026 | $1.41 |
| 2025 | $1.72 |
| 2024 | $1.56 |
| 2023 | $1.40 |
| 2022 | $1.20 |
Thermo Fisher shows a solid dividend growth rate of 12.75% over the last 3 years and 14.34% over the last 5 years, indicating a steady increase in dividend payments and reinforcing confidence in the company’s long-term fiscal health.
| Time Period | Growth |
|---|---|
| 3 years | 12.75% |
| 5 years | 14.34% |
The average dividend growth is 14.34% over 5 years. This shows moderate but steady dividend growth.
The payout ratios are pivotal for assessing sustainability; with an EPS-based payout ratio of 9.17% and an FCF-based payout ratio of 9.32%, Thermo Fisher demonstrates conservative management of its earnings and cash flow, strengthening its dividend reliability.
| Payout Ratio | Percentage |
|---|---|
| EPS-based | 9.17% |
| Free cash flow-based | 9.32% |
Analyzing cash flow and capital efficiency is critical for understanding Thermo Fisher's capability to support operations and dividends. The company has maintained a strong free cash flow yield and a balanced operating cash flow structure, indicating effective capital allocation.
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Free Cash Flow Yield | 3.38% | 3.66% | 2.89% |
| Earnings Yield | 2.93% | 3.19% | 3.09% |
| CAPEX to Operating Cash Flow | 17.59% | 16.15% | 19.51% |
| Stock-based Compensation to Revenue | 0.65% | 0.70% | 0.69% |
| Free Cash Flow / Operating Cash Flow Ratio | 80.49% | 83.85% | 80.49% |
Thermo Fisher maintains a resilient balance sheet with a manageable debt leverage. Their debt metrics, such as Debt-to-Equity and Debt-to-Capital ratios, suggest prudent financial management, enhancing financial stability.
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Debt-to-Equity | 0.78 | 0.66 | 0.76 |
| Debt-to-Assets | 0.37 | 0.34 | 0.37 |
| Debt-to-Capital | 0.44 | 0.40 | 0.43 |
| Net Debt to EBITDA | 2.53 | 2.44 | 2.70 |
Thermo Fisher's ability to generate high returns on equity and assets underscores its operational efficiency. Its profitability margins show an upward trend, demonstrating effective cost management and revenue generation strategies.
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Return on Equity | 12.83% | 12.78% | 12.61% |
| Return on Assets | 6.07% | 6.51% | 6.11% |
| Net Margin | 13.99% | 14.77% | 15.12% |
This scoring system evaluates key dividend criteria on a scale of 1 to 5.
| Criteria | Score | Score Bar |
|---|---|---|
| Dividend yield | 2 | |
| Dividend Stability | 5 | |
| Dividend growth | 4 | |
| Payout ratio | 5 | |
| Financial stability | 4 | |
| Dividend continuity | 5 | |
| Cashflow Coverage | 3 | |
| Balance Sheet Quality | 4 |
Thermo Fisher Scientific Inc. presents a compelling dividend profile, characterized by consistent stability, modest growth, and sound financial management. However, its relatively low dividend yield might not cater to yield-focused investors. Overall, it is a robust candidate for investors emphasizing sustainable growth and capital preservation.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.